ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT.
Pingan Yao(Soochow University), Chungen Xing(Soochow University), Wenqi Shen(Soochow University), Xiaodong Yang(Chinese PLA General Hospital), Wei Zhu(Ministry of Education of the People's Republic of China), Jianping Cao(Soochow University), Yecheng Li(Chengdu Military General Hospital), Xiaohui Xu(Qingdao University)
PubMed
January 1, 2018
Cited by 25
Related Papers
Redefining the invertebrate RNA virosphere
|Nature|2016|1.8k
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168
microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin
|Journal of Biological Chemistry|2010|155